DCM
PRVL

DAFNA Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

DAFNA Capital Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$1.73M Hold
2020
Q3 		$764K Hold
2020
Q2 		$1.12M Hold
2020
Q1 		$914K Hold
2019
Q4 		$1.19M Hold
2019
Q3 		$921K Hold
2019
Q2 		$990K Buy